|
Volumn 7, Issue 1, 2012, Pages 12-15
|
Efficacy and safety of bosentan in adults with simple and complex Eisenmenger's syndrome
|
Author keywords
Adults; Congenital heart disease; Eisenmenger's syndrome
|
Indexed keywords
BOSENTAN;
BRAIN NATRIURETIC PEPTIDE;
ILOPROST;
SILDENAFIL;
ADULT;
AMINOTRANSFERASE BLOOD LEVEL;
ARTERIAL TRUNK;
ARTICLE;
CONGENITAL HEART DISEASE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
EISENMENGER COMPLEX;
FEMALE;
HEART ATRIUM SEPTUM DEFECT;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD REVIEW;
MONOTHERAPY;
OXYGEN CONSUMPTION;
OXYGEN SATURATION;
PATENT DUCTUS ARTERIOSUS;
PRIORITY JOURNAL;
SIDE EFFECT;
TREATMENT RESPONSE;
WALKING;
ADULT;
BIOLOGICAL MARKERS;
CARDIOVASCULAR AGENTS;
EISENMENGER COMPLEX;
EXERCISE TEST;
EXERCISE TOLERANCE;
FEMALE;
HEART DEFECTS, CONGENITAL;
HEMODYNAMICS;
HUMANS;
LOS ANGELES;
MALE;
MIDDLE AGED;
NATRIURETIC PEPTIDE, BRAIN;
OXYGEN;
OXYGEN CONSUMPTION;
RETROSPECTIVE STUDIES;
SULFONAMIDES;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84863035531
PISSN: 1747079X
EISSN: 17470803
Source Type: Journal
DOI: 10.1111/j.1747-0803.2011.00606.x Document Type: Article |
Times cited : (6)
|
References (7)
|